Made Scientific and Regenicin Announce Manufacturing Relationship to Advance NovaDerm Toward FDA Product Approval
Made Scientific to support clinical manufacturing of NovaDerm, an autologous cultured skin substitute for the treatment of severe burns and chronic wounds PRINCETON, N.J., April 22, 2026 /PRNewswire/ -- Made Scientific, Inc., a U.S.-based cell therapy contract development and...
View original →